πŸ‡ΊπŸ‡Έ FDA
Patent

US 8871766

Heterocyclic compounds

granted A61PA61P25/00A61P25/14

Quick answer

US patent 8871766 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18